These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31873806)

  • 21. Population Pharmacokinetics of Voriconazole in Chinese Patients with Hematopoietic Stem Cell Transplantation.
    Chen C; Yang T; Li X; Ma L; Liu Y; Zhou Y; Ren H; Cui Y
    Eur J Drug Metab Pharmacokinet; 2019 Oct; 44(5):659-668. PubMed ID: 31041728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors affecting the pharmacokinetics of tacrolimus (FK506) in hematopoietic cell transplant (HCT) patients.
    Jacobson P; Ng J; Ratanatharathorn V; Uberti J; Brundage RC
    Bone Marrow Transplant; 2001 Oct; 28(8):753-8. PubMed ID: 11781626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Population pharmacokinetics of cyclosporine in kidney and heart transplant recipients and the influence of ethnicity and genetic polymorphisms in the MDR-1, CYP3A4, and CYP3A5 genes.
    Hesselink DA; van Gelder T; van Schaik RH; Balk AH; van der Heiden IP; van Dam T; van der Werf M; Weimar W; Mathot RA
    Clin Pharmacol Ther; 2004 Dec; 76(6):545-56. PubMed ID: 15592326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population Pharmacokinetics of Clofarabine as Part of Pretransplantation Conditioning in Pediatric Subjects before Hematopoietic Cell Transplantation.
    Wang H; Jones AK; Dvorak CC; Huang L; Orchard P; Ivaturi V; Long-Boyle J
    Biol Blood Marrow Transplant; 2019 Aug; 25(8):1603-1610. PubMed ID: 31002993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Population pharmacokinetics analysis of cyclophosphamide with genetic effects in patients undergoing hematopoietic stem cell transplantation.
    Kim IW; Yun HY; Choi B; Han N; Kim MG; Park S; Oh JM
    Eur J Clin Pharmacol; 2013 Aug; 69(8):1543-51. PubMed ID: 23588565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Population pharmacokinetics of mycophenolic acid in renal transplant recipients.
    van Hest RM; van Gelder T; Vulto AG; Mathot RA
    Clin Pharmacokinet; 2005; 44(10):1083-96. PubMed ID: 16176120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Population pharmacokinetics of itraconazole and its active metabolite hydroxy-itraconazole in paediatric cystic fibrosis and bone marrow transplant patients.
    Hennig S; Wainwright CE; Bell SC; Miller H; Friberg LE; Charles BG
    Clin Pharmacokinet; 2006; 45(11):1099-114. PubMed ID: 17048974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in clearance of mycophenolic acid among renal transplant recipients, hematopoietic stem cell transplant recipients, and patients with autoimmune disease.
    de Winter BC; Mathot RA; Sombogaard F; Neumann I; van Hest RM; Doorduijn JK; van Gelder T
    Ther Drug Monit; 2010 Oct; 32(5):606-14. PubMed ID: 20720518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Population pharmacokinetics of cyclosporine in chinese cardiac transplant recipients.
    Yin OQ; Lau SK; Chow MS
    Pharmacotherapy; 2006 Jun; 26(6):790-7. PubMed ID: 16716132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of two population pharmacokinetic programs, NONMEM and P-PHARM, for tacrolimus.
    Staatz CE; Tett SE
    Eur J Clin Pharmacol; 2002 Dec; 58(9):597-605. PubMed ID: 12483452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Population pharmacokinetics of tacrolimus in whole blood and plasma in asian liver transplant patients.
    Sam WJ; Tham LS; Holmes MJ; Aw M; Quak SH; Lee KH; Lim SG; Prabhakaran K; Chan SY; Ho PC
    Clin Pharmacokinet; 2006; 45(1):59-75. PubMed ID: 16430311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Population pharmacokinetic estimation of tacrolimus apparent clearance in adult liver transplant recipients.
    Zahir H; McLachlan AJ; Nelson A; McCaughan G; Gleeson M; Akhlaghi F
    Ther Drug Monit; 2005 Aug; 27(4):422-30. PubMed ID: 16044097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Population pharmacokinetic study of cyclosporine in patients with nephrotic syndrome.
    Xiaoli D; Qiang F
    J Clin Pharmacol; 2009 Jul; 49(7):782-8. PubMed ID: 19448042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Population pharmacokinetics of cyclosporine in clinical renal transplant patients.
    Wu KH; Cui YM; Guo JF; Zhou Y; Zhai SD; Cui FD; Lu W
    Drug Metab Dispos; 2005 Sep; 33(9):1268-75. PubMed ID: 15932953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of cimetidine on ciclosporin population pharmacokinetics and initial dose optimization in aplastic anemia patients.
    Wang DD; He SM; Yang Y; Mao YZ; Yin D; Zheng ZQ; Chen X
    Eur J Pharm Sci; 2022 Jul; 174():106183. PubMed ID: 35398292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Time-dependent pharmacokinetics of cyclosporine (Neoral) in de novo renal transplant patients.
    Lukas JC; Suárez AM; Valverde MP; Calvo MV; Lanao JM; Calvo R; Suarez E; Gil AD
    J Clin Pharm Ther; 2005 Dec; 30(6):549-57. PubMed ID: 16336287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical pharmacology of etoposide in children undergoing autologous stem cell transplantation for various solid tumours.
    Baheti G; McGuire TR; Davda JP; Manouilov KK; Wall D; Gwilt PR; Gordon BB
    Xenobiotica; 2013 Mar; 43(3):276-82. PubMed ID: 22931186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Individualizing oral busulfan dose after using a test dose in patients undergoing hematopoietic stem cell transplantation: pharmacokinetic characterization.
    Effting C; de Moraes Arantes A; Queiroz Labre LV; Carneiro WJ; de Oliveira Neto JR; Bariani C; Rodrigues CR; Rodrigues AR; Cunha LC
    Ther Drug Monit; 2015 Feb; 37(1):66-70. PubMed ID: 25588069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toward better outcomes with tacrolimus therapy: population pharmacokinetics and individualized dosage prediction in adult liver transplantation.
    Staatz CE; Willis C; Taylor PJ; Lynch SV; Tett SE
    Liver Transpl; 2003 Feb; 9(2):130-7. PubMed ID: 12548506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CYP3A5 polymorphism effect on cyclosporine pharmacokinetics in living donor renal transplant recipients: analysis by population pharmacokinetics.
    Song J; Kim MG; Choi B; Han NY; Yun HY; Yoon JH; Oh JM
    Ann Pharmacother; 2012 Sep; 46(9):1141-51. PubMed ID: 22947591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.